{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:02:36Z","timestamp":1787317356012,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s40618-020-01379-2","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T05:04:13Z","timestamp":1599455053000},"page":"957-968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Is there any gender difference in epidemiology, clinical presentation and co-morbidities of non-functioning pituitary adenomas? A prospective survey of a National Referral Center and review of the literature"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5724-1951","authenticated-orcid":false,"given":"C.","family":"Di Somma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Scarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"de Alteriis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9054-456X","authenticated-orcid":false,"given":"L.","family":"Barrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Arianna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3211-4307","authenticated-orcid":false,"given":"S.","family":"Savastano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6986-266X","authenticated-orcid":false,"given":"A.","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"key":"1379_CR1","doi-asserted-by":"publisher","first-page":"R171","DOI":"10.1530\/EJE-15-1272","volume":"175","author":"V Vasilev","year":"2016","unstructured":"Vasilev V, Rostomyan L, Daly AF et al (2016) Pituitary \u201cincidentaloma\u201d: Neuroradiological assessment and differential diagnosis. Eur J Endocrinol 175:R171\u2013R184","journal-title":"Eur J Endocrinol"},{"key":"1379_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11102-018-0869-3","volume":"21","author":"G Ntali","year":"2018","unstructured":"Ntali G, Wass JA (2018) Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary 21:111\u2013118","journal-title":"Pituitary"},{"key":"1379_CR3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.endinu.2017.05.009","volume":"64","author":"M Mercado","year":"2017","unstructured":"Mercado M, Melgar V, Salame L, Cuenca D (2017) Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects. Endocrinol Diabetes Nutr 64:384\u2013395","journal-title":"Endocrinol Diabetes Nutr"},{"key":"1379_CR4","doi-asserted-by":"crossref","unstructured":"Molitch ME (2014) Nonfunctioning pituitary tumors. In: Handbook of clinical neurology","DOI":"10.1016\/B978-0-444-59602-4.00012-5"},{"key":"1379_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-007-0018-x","author":"EH Nielsen","year":"2007","unstructured":"Nielsen EH, Lindholm J, Laurberg P et al (2007) Nonfunctioning pituitary adenoma: Incidence, causes of death and quality of life in relation to pituitary function. Pituitary. https:\/\/doi.org\/10.1007\/s11102-007-0018-x","journal-title":"Pituitary"},{"key":"1379_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.23736\/S0391-1977.18.02946-2","volume":"44","author":"C Lamas","year":"2019","unstructured":"Lamas C, Garcia-Martinez A, Camara R et al (2019) Silent somatotropinomas. Minerva Endocrinol 44:137","journal-title":"Minerva Endocrinol"},{"key":"1379_CR7","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1210\/jc.2018-00688","volume":"10","author":"J Drummond","year":"2019","unstructured":"Drummond J, Roncaroli F, Grossman AB, Korbonits M (2019) Clinical and pathological aspects of silent pituitary adenomas. J Clin Endocrinol Metabol 10:2473\u20132489","journal-title":"J Clin Endocrinol Metabol"},{"key":"1379_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00361","author":"B Aydin","year":"2019","unstructured":"Aydin B, Arga KY (2019) Co-expression network analysis elucidated a core module in association with prognosis of nonfunctioning non-invasive human pituitary adenoma. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2019.00361","journal-title":"Front Endocrinol"},{"key":"1379_CR9","doi-asserted-by":"publisher","DOI":"10.3233\/cbm-191121","author":"K Taniguchi-Ponciano","year":"2020","unstructured":"Taniguchi-Ponciano K, Gomez-Apo E, Chavez-Macias L et al (2020) Molecular alterations in non-functioning pituitary adenomas. Cancer Biomarkers. https:\/\/doi.org\/10.3233\/cbm-191121","journal-title":"Cancer Biomarkers"},{"key":"1379_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4062\/biomolther.2018.103","volume":"26","author":"HI Kim","year":"2018","unstructured":"Kim HI, Lim H, Moon A (2018) Sex differences in cancer: Epidemiology, genetics and therapy. Biomol Therapeutics 26:335","journal-title":"Biomol Therapeutics"},{"key":"1379_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.yfrne.2017.10.003","volume":"50","author":"MV Recouvreux","year":"2018","unstructured":"Recouvreux MV, Faraoni EY, Camilletti MA et al (2018) Sex differences in the pituitary TGF\u03b21 system: The role of TGF\u03b21 in prolactinoma development. Front Neuroendocrinol 50:118\u2013122","journal-title":"Front Neuroendocrinol"},{"key":"1379_CR12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1055\/s-0029-1202831","volume":"117","author":"BD Arasho","year":"2009","unstructured":"Arasho BD, Schaller B, Sandu N, Zenebe G (2009) Gender-related differences in pituitary adenomas. Exper Clin Endocrinol Diabetes 117:567\u2013572","journal-title":"Exper Clin Endocrinol Diabetes"},{"key":"1379_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0779-3","author":"MC Savanelli","year":"2016","unstructured":"Savanelli MC, Scarano E, Muscogiuri G et al (2016) Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D? Endocrine. https:\/\/doi.org\/10.1007\/s12020-015-0779-3","journal-title":"Endocrine"},{"key":"1379_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/nu11010057","author":"L Barrea","year":"2019","unstructured":"Barrea L, Fabbrocini G, Annunziata G et al (2019) Role of nutrition and adherence to the Mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: evaluation of nutritional status and its association with severity of disease. Nutrients. https:\/\/doi.org\/10.3390\/nu11010057","journal-title":"Nutrients"},{"key":"1379_CR15","unstructured":"World Health Organization WHO (2020) https:\/\/www.euro.who.int\/en\/health-topics\/disease-prevention\/nutrition\/a-healthy-lifestyle\/body-mass-index-bmi. Accessed 4 May 2020"},{"key":"1379_CR16","unstructured":"National Center for Health Statistics (2011) No Title. In: January 2011. https:\/\/www.cdc.gov\/nchs\/data\/nhanes\/nhanes_11_12\/Anthropometry_Procedures_Manual.pdf. Accessed 21 May 2020"},{"key":"1379_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486","author":"Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults","year":"2001","unstructured":"Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report (NCEP) -adult treatment panel III. J Am Med Assoc. https:\/\/doi.org\/10.1001\/jama.285.19.2486","journal-title":"J Am Med Assoc"},{"key":"1379_CR18","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N et al (2016) Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline. J Clin Endocrinol Metabol 101:3888\u20133921","journal-title":"J Clin Endocrinol Metabol"},{"key":"1379_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2014.10.006","author":"S Savastano","year":"2015","unstructured":"Savastano S, Di Somma C, Colao A et al (2015) Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone\/insulin-like growth factor-1 status. Growth Hormon IGF Res. https:\/\/doi.org\/10.1016\/j.ghir.2014.10.006","journal-title":"Growth Hormon IGF Res"},{"key":"1379_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2015.12.007","author":"L Barrea","year":"2015","unstructured":"Barrea L, Di Somma C, Macchia PE et al (2015) Influence of nutrition on somatotropic axis: milk consumption in adult individuals with moderate-severe obesity. Clin Nutr. https:\/\/doi.org\/10.1016\/j.clnu.2015.12.007","journal-title":"Clin Nutr"},{"key":"1379_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/nu10121854","author":"L Barrea","year":"2018","unstructured":"Barrea L, Altieri B, Muscogiuri G et al (2018) Impact of nutritional status on gastroenteropancreatic neuroendocrine tumors (GEP-NET) aggressiveness. Nutrients. https:\/\/doi.org\/10.3390\/nu10121854","journal-title":"Nutrients"},{"key":"1379_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6101254","author":"L Barrea","year":"2017","unstructured":"Barrea L, Tarantino G, Di SC et al (2017) Adherence to the Mediterranean diet and circulating levels of Sirtuin 4 in obese patients: a novel association. Oxidat Med Cell Longevity. https:\/\/doi.org\/10.1155\/2017\/6101254","journal-title":"Oxidat Med Cell Longevity"},{"key":"1379_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-018-2193-0","author":"L Barrea","year":"2018","unstructured":"Barrea L, Muscogiuri G, Di Somma C et al (2018) Coffee consumption, metabolic syndrome and clinical severity of psoriasis: good or bad stuff? Arch Toxicol. https:\/\/doi.org\/10.1007\/s00204-018-2193-0","journal-title":"Arch Toxicol"},{"key":"1379_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/730827","author":"MC Amato","year":"2014","unstructured":"Amato MC, Giordano C (2014) Visceral adiposity index: an indicator of adipose tissue dysfunction. Int J Endocrinol. https:\/\/doi.org\/10.1155\/2014\/730827","journal-title":"Int J Endocrinol"},{"key":"1379_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-10-183","author":"MC Amato","year":"2011","unstructured":"Amato MC, Giordano C, Pitrone M, Galluzzo A (2011) Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids in Health and Disease. https:\/\/doi.org\/10.1186\/1476-511X-10-183","journal-title":"Lipids in Health and Disease"},{"key":"1379_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-6-33","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L et al (2006) The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology. https:\/\/doi.org\/10.1186\/1471-230X-6-33","journal-title":"BMC Gastroenterology"},{"issue":"885","key":"1379_CR27","first-page":"903","volume":"15","author":"GA Kaltsas","year":"2008","unstructured":"Kaltsas GA, Evanson J, Chrisoulidou A, Grossman AB (2008) The diagnosis and management of parasellar tumours of the pituitary. Endocr Relat Cancer 15(885):903","journal-title":"Endocr Relat Cancer"},{"key":"1379_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03667.x","author":"A Fernandez","year":"2010","unstructured":"Fernandez A, Karavitaki N, Wass JAH (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in (Oxfordshire, UK). Clin Endocrinol. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03667.x","journal-title":"Clin Endocrinol"},{"key":"1379_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.11.186","author":"D Solari","year":"2019","unstructured":"Solari D, Zenga F, Angileri FF et al (2019) A survey on pituitary surgery in Italy. World Neurosurg. https:\/\/doi.org\/10.1016\/j.wneu.2018.11.186","journal-title":"World Neurosurg"},{"key":"1379_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.beem.2009.05.008","volume":"23","author":"AF Daly","year":"2009","unstructured":"Daly AF, Tichomirowa MA, Beckers A (2009) The epidemiology and genetics of pituitary adenomas. Best Pract Res Clin Endocrinol Metabol 23:543\u2013554","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"1379_CR31","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480325","author":"A Colao","year":"2003","unstructured":"Colao A, Di Sarno A, Cappabianca P et al (2003) Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje.0.1480325","journal-title":"Eur J Endocrinol"},{"key":"1379_CR32","first-page":"425","volume":"24","author":"B Schaller","year":"2003","unstructured":"Schaller B (2003) Gender-related differences in non-functioning pituitary adenomas. Neuroendocrinol Lett 24:425\u2013430","journal-title":"Neuroendocrinol Lett"},{"key":"1379_CR33","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-115645","author":"P Iglesias","year":"2017","unstructured":"Iglesias P, Arcano K, Trivi\u00f1o V et al (2017) Prevalence, clinical features, and natural history of incidental clinically non-functioning pituitary adenomas. Horm Metab Res. https:\/\/doi.org\/10.1055\/s-0043-115645","journal-title":"Horm Metab Res"},{"key":"1379_CR34","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0144","author":"A Tj\u00f6rnstrand","year":"2014","unstructured":"Tj\u00f6rnstrand A, Gunnarsson K, Evert M et al (2014) The incidence rate of pituitary adenomas in western Sweden for the period 2001\u20132011. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-14-0144","journal-title":"Eur J Endocrinol"},{"key":"1379_CR35","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0189","author":"TT Agustsson","year":"2015","unstructured":"Agustsson TT, Baldvinsdottir T, Jonasson JG et al (2015) The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-15-0189","journal-title":"Eur J Endocrinol"},{"key":"1379_CR36","doi-asserted-by":"publisher","first-page":"791","DOI":"10.4103\/2230-8210.167551","volume":"19","author":"FB Zerehpoosh","year":"2015","unstructured":"Zerehpoosh FB, Sabeti S, Sharifi G et al (2015) Demographic study of pituitary adenomas undergone trans-sphenoidal surgery in Loghman Hakim Hospital, Tehran, Iran 2001\u20132013. Indian J Endocrinol Metabol 19:791","journal-title":"Indian J Endocrinol Metabol"},{"key":"1379_CR37","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000195","author":"P Fainstein Day","year":"2016","unstructured":"Fainstein Day P, Loto MG, Glerean M et al (2016) Incidence and prevalence of clinically relevant pituitary adenomas: Retrospective cohort study in a health management organization in Buenos Aires, Argentina. Arch Endocrinol Metabol. https:\/\/doi.org\/10.1590\/2359-3997000000195","journal-title":"Arch Endocrinol Metabol"},{"key":"1379_CR38","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0065","author":"NM Vaninetti","year":"2018","unstructured":"Vaninetti NM, Clarke DB, Zwicker DA et al (2018) A comparative, population-based analysis of pituitary incidentalomas vs clinically manifesting sellar masses. Endocrine Connect. https:\/\/doi.org\/10.1530\/EC-18-0065","journal-title":"Endocrine Connect"},{"key":"1379_CR39","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.63.P1106","author":"MN Aguirre","year":"2019","unstructured":"Aguirre MN, Sampedro-Nunez M, Levi AR et al (2019) Analysis of gender-related differences in clinically non-functioning pituitary adenomas. Endocrine Abstracts. https:\/\/doi.org\/10.1530\/endoabs.63.P1106","journal-title":"Endocrine Abstracts"},{"key":"1379_CR40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.beem.2012.01.002","volume":"26","author":"O Cooper","year":"2012","unstructured":"Cooper O, Melmed S (2012) Subclinical hyperfunctioning pituitary adenomas: the silent tumors. Best Pract Res Clin Endocrinol Metabol 26:447\u2013460","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"1379_CR41","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2010.184","author":"P Katavetin","year":"2010","unstructured":"Katavetin P, Cheunsuchon P, Grant E et al (2010) Rathke\u2019s cleft cysts in children and adolescents: Association with female puberty. J Pediatr Endocrinol Metab. https:\/\/doi.org\/10.1515\/jpem.2010.184","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1379_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199910000-00008","author":"K Wester","year":"1999","unstructured":"Wester K (1999) Peculiarities of intracranial arachnoid cysts: Location, sidedness, and sex distribution in 126 consecutive patients. Neurosurgery. https:\/\/doi.org\/10.1097\/00006123-199910000-00008","journal-title":"Neurosurgery"},{"key":"1379_CR43","doi-asserted-by":"publisher","DOI":"10.3171\/2009.11.JNS081663","author":"CA Helland","year":"2010","unstructured":"Helland CA, Lund-Johansen M, Wester K (2010) Location, sidedness, and sex distribution of intracranial arachnoid cysts in a population-based sample. J Neurosurg. https:\/\/doi.org\/10.3171\/2009.11.JNS081663","journal-title":"J Neurosurg"},{"key":"1379_CR44","doi-asserted-by":"publisher","DOI":"10.1159\/000497746","author":"L Vroonen","year":"2019","unstructured":"Vroonen L, Daly AF, Beckers A (2019) Epidemiology and management challenges in prolactinomas. Neuroendocrinology. https:\/\/doi.org\/10.1159\/000497746","journal-title":"Neuroendocrinology"},{"key":"1379_CR45","unstructured":"Istituto Superiore di Sanit\u00e0 (2018) La sorveglianza PASSI 2018. https:\/\/www.epicentro.iss.it\/passi\/infoPassi\/archivio2018. Accessed 25 Jul 2020"},{"key":"1379_CR46","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2002.00981.x","author":"A Lania","year":"2002","unstructured":"Lania A, Gangi E, Romoli R et al (2002) Impaired estrogen-induced negative feedback on gonadotropin secretion in patients with gonadotropin-secreting and nonfunctioning pituitary adenomas. Eur J Clin Invest. https:\/\/doi.org\/10.1046\/j.1365-2362.2002.00981.x","journal-title":"Eur J Clin Invest"},{"key":"1379_CR47","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.12.8530610","author":"M Zafar","year":"1995","unstructured":"Zafar M, Ezzat S, Ramyar L et al (1995) Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.80.12.8530610","journal-title":"J Clin Endocrinol Metab"},{"key":"1379_CR48","doi-asserted-by":"publisher","DOI":"10.1159\/000077269","author":"JFS Pereira-Lima","year":"2004","unstructured":"Pereira-Lima JFS, Marroni CP, Pizarro CB et al (2004) Immunohistochemical detection of estrogen receptor alpha in pituitary adenomas and its correlation with cellular replication. Neuroendocrinology. https:\/\/doi.org\/10.1159\/000077269","journal-title":"Neuroendocrinology"},{"key":"1379_CR49","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1065338","author":"JA Burdman","year":"2008","unstructured":"Burdman JA, Pauni M, Heredia Sereno CM, Bord\u00f3n AE (2008) Estrogen receptors in human pituitary tumors. Horm Metab Res. https:\/\/doi.org\/10.1055\/s-2008-1065338","journal-title":"Horm Metab Res"},{"key":"1379_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-018-0116-7","author":"H Hua","year":"2018","unstructured":"Hua H, Zhang H, Kong Q, Jiang Y (2018) Mechanisms for estrogen receptor expression in human cancer. Exper Hematol Oncol. https:\/\/doi.org\/10.1186\/s40164-018-0116-7","journal-title":"Exper Hematol Oncol"},{"key":"1379_CR51","doi-asserted-by":"publisher","DOI":"10.1177\/1066896912471850","author":"K Zhou","year":"2013","unstructured":"Zhou K, Jin H, Luo Y (2013) Expression and significance of E-cadherin and \u03b2-catenins in pituitary adenoma. Int J Surg Pathol. https:\/\/doi.org\/10.1177\/1066896912471850","journal-title":"Int J Surg Pathol"},{"key":"1379_CR52","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00792","author":"KA Oystese","year":"2017","unstructured":"Oystese KA, Casar-Borota O, Normann KR et al (2017) Estrogen receptor a, a sex-dependent predictor of aggressiveness in nonfunctioning pituitary adenomas: Sstr and sex hormone receptor distribution in NFPA. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2017-00792","journal-title":"J Clin Endocrinol Metab"},{"key":"1379_CR53","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ctrv.2008.05.007","volume":"34","author":"A Makri","year":"2008","unstructured":"Makri A, Pissimissis N, Lembessis P et al (2008) The kisspeptin (KiSS-1)\/GPR54 system in cancer biology. Cancer Treat Rev 34:682\u2013692","journal-title":"Cancer Treat Rev"},{"key":"1379_CR54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.yfrne.2013.11.003","volume":"35","author":"M Bailey","year":"2014","unstructured":"Bailey M, Silver R (2014) Sex differences in circadian timing systems: implications for disease. Front Neuroendocrinol 35:111\u2013139","journal-title":"Front Neuroendocrinol"},{"key":"1379_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2016.07.039","author":"MD Gahete","year":"2016","unstructured":"Gahete MD, V\u00e1zquez-Borrego MC, Mart\u00ednez-Fuentes AJ et al (2016) Role of the Kiss1\/Kiss1r system in the regulation of pituitary cell function. Mol Cell Endocrinol. https:\/\/doi.org\/10.1016\/j.mce.2016.07.039","journal-title":"Mol Cell Endocrinol"},{"key":"1379_CR56","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0905","author":"AJ Mart\u00ednez-Fuentes","year":"2011","unstructured":"Mart\u00ednez-Fuentes AJ, Molina M, V\u00e1zquez-Mart\u00ednez R et al (2011) Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-10-0905","journal-title":"Eur J Endocrinol"},{"key":"1379_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0572-y","author":"M Yaron","year":"2015","unstructured":"Yaron M, Renner U, Gilad S et al (2015) KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors. Pituitary. https:\/\/doi.org\/10.1007\/s11102-014-0572-y","journal-title":"Pituitary"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01379-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01379-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01379-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T19:04:39Z","timestamp":1630955079000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01379-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1379"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01379-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]},"assertion":[{"value":"23 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study design was made in accordance with the Helsinki II Declaration for Study on human experimentation and approved by the local ethic committee (n. 63\/97).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients signed their informed consent. Consent for publication: The study design was made in accordance with the Helsinki II Declaration for Study on human experimentation and approved by the local ethic committee (n. 63\/97),","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}